Literature DB >> 3921030

Imidazole antimycotics: inhibitors of steroid aromatase.

J I Mason, B A Murry, M Olcott, J J Sheets.   

Abstract

Miconazole and clotrimazole, members of a class of imidazole agents which have broad spectrum antimycotic activity, were shown to be potent inhibitors of steroid aromatase activity of human placental microsomes. The I50 values for the inhibition of aromatase activity by miconazole, clotrimazole, ketoconazole, and aminoglutethimide were 0.6, 1.8, 60 and 44 microM respectively. The most effective compound, miconazole, exhibited competitive kinetics with respect to androstenedione, the aromatase substrate. The apparent inhibitory constant (Ki) was 55 nM, under assay conditions where the apparent Km for androstenedione was 220 nM. The inhibition of aromatase activity by miconazole was shown to be reversible by dilution. Miconazole was a relatively poor inhibitor of the cholesterol side chain cleavage activity of a placental mitochondria-enriched fraction, while both clotrimazole and ketoconazole markedly inhibited this mitochondrial monooxygenase activity. Spectrophotometric studies revealed that miconazole bound to the cytochrome P-450 component of the placental microsomal aromatase complex and had negligible effect on NADPH-cytochrome c (P-450) reductase activity. These results strongly support direct interaction of miconazole with microsomal cytochrome P-450 in human placental microsomes with high affinity resulting in the inhibition of aromatase activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921030     DOI: 10.1016/0006-2952(85)90613-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

1.  Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.

Authors:  T Tiffert; H Ginsburg; M Krugliak; B C Elford; V L Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase.

Authors:  S H Bae; Y K Paik
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  Effect of cytochrome P-450 inhibitors econazole, bifonazole and clotrimazole on prostanoid formation.

Authors:  H C Köfeler; G Fauler; W Windischhofer; H J Leis
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Fluconazole and testosterone: in vivo and in vitro studies.

Authors:  D P Hanger; S Jevons; J T Shaw
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

5.  Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.

Authors:  M H Devenport; D Crook; V Wynn; L J Lees
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

6.  Characterization of the steroid-metabolizing capacity of the hepatic cytochrome P450IIC5 expressed in COS-1 cells: 3 beta-hydroxysteroid dehydrogenase/delta 5----4 isomerase type activity.

Authors:  J M Trant; M C Lorence; E F Johnson; C H Shackleton; J I Mason; R W Estabrook
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Cytochrome P-450-dependent 14 alpha-demethylation of lanosterol in Candida albicans.

Authors:  C A Hitchcock; S B Brown; E G Evans; D J Adams
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

8.  Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone.

Authors:  Z Y Hu; E Bourreau; I Jung-Testas; P Robel; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  Mechanism of inhibition of estrogen biosynthesis by azole fungicides.

Authors:  Chinaza Egbuta; Jessica Lo; Debashis Ghosh
Journal:  Endocrinology       Date:  2014-09-22       Impact factor: 4.736

10.  Effect of a single administration of ketoconazole on total and physiologically free plasma testosterone and 17 beta-oestradiol levels in healthy male volunteers.

Authors:  R De Coster; I Caers; C Haelterman; M Debroye
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.